Clinical Trial Update: Irinotecan and Cetuximab in Treating Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating the combination of irinotecan and cetuximab in patients with metastatic breast cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Camptosar (irinotecan)
• ERBITUX (cetuximab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED